U.S., March 7 -- ClinicalTrials.gov registry received information related to the study (NCT07455058) titled 'Water Vapor Ablation for Prostate Cancer: Long-Term Registry' on Feb. 26.
Brief Summary: The purpose of the registry is to evaluate real-world safety, efficacy, and patient reported outcomes among participants receiving Vanquish Water Vapor Ablation System therapy (Vanquish Therapy). This includes longitudinal assessment of patients who have received or will receive the therapy one or multiple times as part of routine clinical care and encompasses those who completed a company-sponsored Vanquish therapy study (as applicable).
Study Start Date: April 30
Study Type: OBSERVATIONAL
Condition:
Prostate Cancer
Intervention:
DEVICE: ...